ArticleWorld journal of clinical oncology2022

iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers.

Xuan-Yu Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.